Product Information
CETROTIDE 0.25 MG VIAL is a brand product labeled by EMD Serono, Inc., priced at $306.0574 per EA under NDC 44087122501. Its NADAC has been published 61 times since Nov 20, 2024.
Manufacturer
EMD Serono, Inc.NDC
44087122501
Classification
Brand
Dosage Form
KIT
Route
SUBCUTANEOUS
Last Updated
1/29/2025
Approval Type
New Drug (NDA)
FDA Application
NDA021197On Market Since
8/11/2000
Price Statistics
The NADAC for CETROTIDE 0.25 MG VIAL has been published 61 times since Nov 20, 2024, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $306.0574 per EA |
|---|---|
| All-time high | $306.0574 (Jan 14, 2026) |
| All-time low | $291.4860 (Nov 20, 2024) |
| 52-week high | $306.0574 |
| 52-week low | $306.0574 |
| Median price | $306.0574 |
| Average price | $303.4298 |
| Largest weekly change | +5.0% (Feb 5, 2025) |
| Weeks tracked | 61 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cetrorelix acetate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CETROTIDE 0.25 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CETROTIDE 0.25 MG VIAL, manufactured by EMD Serono, Inc., is $306.0574 per EA (NDC 44087122501), effective Jan 14, 2026.
How has the price of CETROTIDE 0.25 MG VIAL changed over time?
Over the history we have for it, the NADAC for CETROTIDE 0.25 MG VIAL has risen 5.0%. It has been tracked across 61 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for CETROTIDE 0.25 MG VIAL?
Since Nov 20, 2024, the NADAC for CETROTIDE 0.25 MG VIAL has ranged from a low of $291.4860 (Nov 20, 2024) to a high of $306.0574 (Jan 14, 2026), with a median of $306.0574 per EA.
Are there cheaper alternatives to CETROTIDE 0.25 MG VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CETROTIDE 0.25 MG VIAL, so no direct lower-cost alternative is listed.
Who manufactures CETROTIDE 0.25 MG VIAL?
CETROTIDE 0.25 MG VIAL (NDC 44087122501) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification